Cargando…
Population pharmacokinetic analysis of enrofloxacin and its active metabolite ciprofloxacin after intravenous injection to cats with reduced kidney function
BACKGROUND: It is unknown if enrofloxacin accumulates in plasma of cats with reduced kidney function. HYPOTHESIS: To determine if enrofloxacin and its active metabolite ciprofloxacin have reduced clearance in azotemic cats. ANIMALS: Thirty‐four cats hospitalized for clinical illness with variable de...
Autores principales: | Foster, Jonathan D., Abouraya, Mahmoud, Papich, Mark G., Muma, Nancy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658592/ https://www.ncbi.nlm.nih.gov/pubmed/37728198 http://dx.doi.org/10.1111/jvim.16866 |
Ejemplares similares
-
Ciprofloxacin Pharmacokinetics in Clinical Canine Patients
por: Papich, M.G.
Publicado: (2017) -
Posaconazole Pharmacokinetics in Healthy Cats after Oral and Intravenous Administration
por: Mawby, D.I., et al.
Publicado: (2016) -
Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs
por: KuKanich, K., et al.
Publicado: (2016) -
The pharmacokinetics of gabapentin in cats
por: Adrian, Derek, et al.
Publicado: (2018) -
Pharmacokinetics of isavuconazole in healthy cats after oral and intravenous administration
por: Woerde, Dennis J., et al.
Publicado: (2022)